Your session is about to expire
← Back to Search
Other
Early Intervention Strategies for Undiagnosed Asthma and COPD
N/A
Waitlist Available
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will assess the burden of undiagnosed respiratory disease in Canadian communities and whether early treatment of airflow obstruction will improve patients' health outcomes.
Who is the study for?
The UCAP study is for Canadian adults who may have undiagnosed asthma or COPD, as indicated by specific questionnaire scores. Participants must be able to perform lung function tests and not have a prior diagnosis of these conditions. Pregnant women in their third trimester and individuals with recent severe cardiovascular or eye issues are excluded.Check my eligibility
What is being tested?
This trial aims to identify people with undiagnosed asthma or COPD using targeted casefinding, then assess if early treatment based on established guidelines can improve health outcomes. It includes education and smoking cessation support as part of the intervention strategy.See study design
What are the potential side effects?
Since this trial involves standard treatments for asthma and COPD following evidence-based guidelines, potential side effects could include medication-related reactions like coughing, headaches, nausea, and possible irritation from inhalers used.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Annual rate of patient initiated healthcare utilization events for respiratory illness
Secondary outcome measures
Change in disease-specific quality of life quantified using the St. George's Respiratory Questionnaire (SGRQ).
Changes in forced expiratory volume in one second (FEV1) measured in litres (L) using pre bronchodilator spirometry testing and post bronchodilator spirometry testing.
Changes in overall respiratory symptoms (including cough, sputum and dyspnea) will be assessed using the COPD Assessment Test (CAT)
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Enhanced CareActive Control3 Interventions
Treatment strategy using evidence-based guidelines for asthma or COPD
Group II: Standard of CarePlacebo Group1 Intervention
Spirometry result sent to family MD
Find a Location
Who is running the clinical trial?
Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,183 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with asthma by a doctor before.In the past 3 months, you had a heart attack, stroke, aneurysm, detached retina, or eye surgery.You have a high score on the asthma screening questionnaire or the COPD diagnostic questionnaire.People with breathing problems that are not diagnosed yet will have the option to join the study if their lung function improves after using a bronchodilator.You can do a breathing test before and after taking medicine to measure your lung function.You have been diagnosed with COPD by a doctor in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced Care
- Group 2: Standard of Care
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there numerous health centers in the city that are undertaking this clinical experiment?
"At this time, 17 distinct clinics have opened their doors to participants for this study. Centres are located in Edmonton, Winnipeg, Montréal and other nearby locations. To limit travel needs upon enrollment, it is paramount that potential volunteers select the closest medical facility."
Answered by AI
Are any participants being recruited for this medical trial at present?
"Clinicaltrials.gov reveals that this medical study is not currently enlisting patients, despite first being listed on June 5th 2017 and most recently edited on October 12th 2022. Nevertheless, there are 572 other trials actively recruiting individuals for participation at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger